1.High Glucose Causes Human Cardiac Progenitor Cell Dysfunction by Promoting Mitochondrial Fission: Role of a GLUT1 Blocker.
He Yun CHOI ; Ji Hye PARK ; Woong Bi JANG ; Seung Taek JI ; Seok Yun JUNG ; Da Yeon KIM ; Songhwa KANG ; Yeon Ju KIM ; Jisoo YUN ; Jae Ho KIM ; Sang Hong BAEK ; Sang Mo KWON
Biomolecules & Therapeutics 2016;24(4):363-370
Cardiovascular disease is the most common cause of death in diabetic patients. Hyperglycemia is the primary characteristic of diabetes and is associated with many complications. The role of hyperglycemia in the dysfunction of human cardiac progenitor cells that can regenerate damaged cardiac tissue has been investigated, but the exact mechanism underlying this association is not clear. Thus, we examined whether hyperglycemia could regulate mitochondrial dynamics and lead to cardiac progenitor cell dysfunction, and whether blocking glucose uptake could rescue this dysfunction. High glucose in cardiac progenitor cells results in reduced cell viability and decreased expression of cell cycle-related molecules, including CDK2 and cyclin E. A tube formation assay revealed that hyperglycemia led to a significant decrease in the tube-forming ability of cardiac progenitor cells. Fluorescent labeling of cardiac progenitor cell mitochondria revealed that hyperglycemia alters mitochondrial dynamics and increases expression of fission-related proteins, including Fis1 and Drp1. Moreover, we showed that specific blockage of GLUT1 improved cell viability, tube formation, and regulation of mitochondrial dynamics in cardiac progenitor cells. To our knowledge, this study is the first to demonstrate that high glucose leads to cardiac progenitor cell dysfunction through an increase in mitochondrial fission, and that a GLUT1 blocker can rescue cardiac progenitor cell dysfunction and downregulation of mitochondrial fission. Combined therapy with cardiac progenitor cells and a GLUT1 blocker may provide a novel strategy for cardiac progenitor cell therapy in cardiovascular disease patients with diabetes.
Cardiovascular Diseases
;
Cause of Death
;
Cell Survival
;
Cyclin E
;
Cyclins
;
Diabetic Cardiomyopathies
;
Down-Regulation
;
Glucose*
;
Humans*
;
Hyperglycemia
;
Mitochondria
;
Mitochondrial Dynamics*
;
Stem Cells*
2.Reactive oxygen species-dependent apoptosis induction by water extract of Citrus unshiu peel in MDA-MB-231 human breast carcinoma cells.
Min Yeong KIM ; Eun Ok CHOI ; Hyun HWANGBO ; Da He KWON ; Kyu Im AHN ; Hong Jae KIM ; Seon Yeong JI ; Su Hyun HONG ; Jin Woo JEONG ; Gi Young KIM ; Cheol PARK ; Yung Hyun CHOI
Nutrition Research and Practice 2018;12(2):129-134
BACKGROUND/OBJECTIVES: Although several recent studies have reported the anti-cancer effects of extracts or components of Citrus unshiu peel, which has been used for various purposes in traditional medicine, the molecular mechanisms for their effects remain unclear. In the present study, the anti-cancer activity of a water-soluble extract of C. unshiu peel (WECU) in MDA-MB-231 human breast carcinoma cells at the level of apoptosis induction was investigated. MATERIALS/METHODS: Cytotoxicity was evaluated using the MTT assay. Apoptosis was detected using DAPI staining and flow cytometry analyses. Mitochondrial membrane potential, reactive oxygen species (ROS) assay, caspase activity and Western blotting were used to confirm the basis of apoptosis. RESULTS: The results indicated that WECU-induced apoptosis was related to the activation of caspase-8, and -9, representative initiator caspases of extrinsic and intrinsic apoptosis pathways, respectively, and caspase-3 accompanied by proteolytic degradation of poly(ADP-ribose) polymerase and down-regulation of the inhibitors of apoptosis protein family members. WECU also increased the pro-apoptotic BAX to anti-apoptotic BCL-2 ratio, loss of mitochondrial membrane potential and cytochrome c release from mitochondria to cytoplasm. Furthermore, WECU provoked the generation of ROS, but the reduction of cell viability and induction of apoptosis by WECU were prevented when ROS production was blocked by antioxidant N-acetyl cysteine. CONCLUSIONS: These results suggest that WECU suppressed proliferation of MDA-MB-231 cells by activating extrinsic and intrinsic apoptosis pathways in a ROS-dependent manner.
Apoptosis*
;
Blotting, Western
;
Breast Neoplasms*
;
Breast*
;
Caspase 3
;
Caspase 8
;
Caspases, Initiator
;
Cell Survival
;
Citrus*
;
Cysteine
;
Cytochromes c
;
Cytoplasm
;
Down-Regulation
;
Flow Cytometry
;
Humans*
;
Medicine, Traditional
;
Membrane Potential, Mitochondrial
;
Mitochondria
;
Oxygen*
;
Poly(ADP-ribose) Polymerases
;
Reactive Oxygen Species
;
Water*
3.Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats.
Hyun HWANGBO ; Da He KWON ; Eun Ok CHOI ; Min Yeong KIM ; Kyu Im AHN ; Seon Yeong JI ; Jong Sik KIM ; Kyung Il KIM ; No Jin PARK ; Bum Hoi KIM ; Gi Young KIM ; Su Hyun HONG ; Cheol PARK ; Ji Suk JEONG ; Yung Hyun CHOI
Nutrition Research and Practice 2018;12(5):378-386
BACKGROUND/OBJECTIVES: Benign prostatic hypertrophy (BPH) is a major cause of abnormal overgrowth of the prostate mainly in the elderly. Corni Fructus has been reported to be effective in the prevention and treatment of various diseases because of its strong antioxidant effect, but its efficacy against BPH is not yet known. This study was designed to evaluate the therapeutic efficacy of Corni Fructus water extract (CF) in testosterone-induced BPH rats. MATERIALS/METHODS: To induce BPH, rats were intraperitoneal injected with testosterone propionate (TP). Rats in the treatment group were orally administered with CF with TP injection, and finasteride, which is a selective inhibitor of 5α-reductase type 2, was used as a positive control. RESULTS: Our results showed that the increased prostate weight and histopathological changes in BPH model rats were suppressed by CF treatment. CF, similar to the finasteride-treated group, decreased the levels of testosterone and dihydrotestosterone by TP treatment in the serum, and it also reduced 5α-reductase expression and concentration in prostate tissue and serum, respectively. In addition, CF significantly blocked the expression of the androgen receptor (AR), AR co-activators, and proliferating cell nuclear antigen in BPH rats, and this blocking was associated with a decrease in prostate-specific antigen levels in serum and prostate tissue. CONCLUSIONS: These results suggest that CF may weaken the BPH status through the inactivation of at least 5α-reductase and AR activity and may be useful for the clinical treatment of BPH.
Aged
;
Animals
;
Antioxidants
;
Cornus*
;
Dihydrotestosterone
;
Finasteride
;
Humans
;
Proliferating Cell Nuclear Antigen
;
Prostate
;
Prostate-Specific Antigen
;
Prostatic Hyperplasia*
;
Rats*
;
Receptors, Androgen*
;
Testosterone
;
Testosterone Propionate
;
Water